Facility Prefabrication – Coupling Flexibility, Mobility and Rapid Deployment into Turnkey Solutions

Facility Prefabrication – Coupling Flexibility, Mobility and Rapid Deployment into Turnkey Solutions

04/18/2018, 4:15 PM - 5:00 PM

Technical Conference Stage 2, Booth 1177, Exhibit Hall


For too long, our industry has been creating legacy solutions to address a need of the past. However, manufacturing needs are evolving rapidly and new solutions are required. Solutions which address faster time-to-run, capacity flexing to avoid stock-outs and drug shortage and novel processing spaces for new therapies. As an industry, we have evaluated ways to bring a facility online sooner and faster, but often new formats created the same concepts used. From stick built facilities, to modular facilities, to prefabricated, container based facilities each evolving model strives to address a key driver in our industry, how can we get drugs to our patients faster with the sufficient capacities? However, there are still instances where facilities are designed, constructed, and mothballed without ever opening, due to late development failure of the drug. Or a major capital investment is desperately made to an existing site due to unforeseen capacity needs, often only for one product and one product lifecycle. While speed to market is improving, facilities today lack the flexibility and mobility to address any unplanned event. The turnkey prefabricated model is a novel concept in facility design, was developed to address the needs we cannot anticipate within a fast track timeframe requested by the industry. Coupling Flexibility, Mobility and Rapid Deployment into a Turnkey Facility, the predesigned and prefabricated model was developed to truly address our industries agility, repurposability and investment needs. Harnessing the power of concurrent manufacturing, this new facilities concept would be prefabricated at center of excellences, allowing rapid deployment of new facilities throughout the world. The platform design gives manufacturers the flexibility to migrate between multiple clinical manufacturing suites to a commercial 4x2000L production facility or anywhere in between. For future molecules whose process we cannot currently anticipate, the facility includes novel cleanroom technology which enables clients to remove single to multiple suites to easily retrofit a facility instead of mothballing it.


  • Peter Makowenskyj


    Sales Engineer


  • Tom Piombino, PE


    Sr. Director, Process Architect

    IPS - Integrated Project Services

    Mr. Piombino has a background in estimating, engineering, architecture, bioprocess, construction, and portfolio program management, He has been...

Type of Session

  1. Type of Session

Learning Objectives

  1. Learning Objectives 1. Understanding existing limiations of facility designs. 2. Introduction of iCON™ and how it came to be. 3. iCON™ – Coupling Flexibility, Mobility and Rapid Deployment into Turnkey Solutions


  1. Track
    Optimizing Facilities through Innovation & Technologies

We use cookies to operate this website and to improve its usability. Full details of what cookies are, why we use them and how you can manage them can be found by reading our Privacy & Cookies page. Please note that by using this site you are consenting to the use of cookies.